4//SEC Filing
Gryaznov Sergei 4
Accession 0001127602-24-002276
CIK 0001878313other
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 4:10 PM ET
Size
5.3 KB
Accession
0001127602-24-002276
Insider Transaction Report
Form 4
Gryaznov Sergei
Chief Scientific Officer
Transactions
- Award
Stock Options
2024-01-24+100,000→ 100,000 totalExercise: $1.41Exp: 2034-01-24→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The stock options, granted on January 24, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of the grant and the remaining options to vest ratably monthly thereafter for 36 months.
Documents
Issuer
MAIA Biotechnology, Inc.
CIK 0001878313
Entity typeother
Related Parties
1- filerCIK 0001913228
Filing Metadata
- Form type
- 4
- Filed
- Jan 25, 7:00 PM ET
- Accepted
- Jan 26, 4:10 PM ET
- Size
- 5.3 KB